Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis

Mantha, S., Karp, R., Raghavan, V., Terrin, N., Bauer, K. A., Zwicker, J. I.·2012·BMJ
DOI 10.1136/bmj.e4944

Cited by (257)

Items 101–200 of 257

  1. Contraception : Recommandations pour la Pratique Clinique du CNGOF (texte court)
    Nathalie Chabbert‐Buffet, Henri Marret, Aubert Agostini, Chloé Cardinale, N. Hamdaoui, Danielle Hassoun, A.‐P. Jonville‐Béra, M. Lambert, Teddy Linet, Catherine Pienkowski et al. · 2018 · Gynécologie Obstétrique Fertilité & Sénologie
  2. Disease activity and thromboembolic events in women with systemic lupus erythematosus with and without anti-phospholipid syndrome: users of the 52-mg levonorgestrel-releasing intrauterine system
    Rafaella Colicigno Rebelo, Estephania Pignaton Naseri, Maria Valeria Bahamondes, Lílian Tereza Lavras Costallat, Simone Appenzeller, Luis Guillermo Bahamondes, Arlete Maria dos Santos Fernandes · 2019 · Archives of Gynecology and Obstetrics
  3. Effects of the COVID-19 Pandemic on Gynecological Health: An Integrative Review
    Gisele Vissoci Marquini, Sérgio Brasileiro Martins, Letícia Maria de Oliveira, Márcia Maria Dias, Cláudia Cristina Takano, Marair Grácio Ferreira Sartori · 2022 · Revista Brasileira Ginecologia e Obstetrícia
  4. Toward a new concept of “natural balance” in oral estroprogestin contraception
    Nathalie Chabbert‐Buffet, Jan Gerris, C. Jamin, Stefano Lello, Iñaki Lete, Paloma Lobo, Rossella Elena Nappi, Axelle Pintiaux · 2013 · Gynecological Endocrinology
  5. FSRH Guideline (August 2022) Progestogen-only Pills
    2022 · BMJ Sexual & Reproductive Health
  6. Contraception and family planning at the extreme of reproductive life – climacteric
    Zsuzsanna Ilona Katalin de Jármy Di Bella, Ana Maria Homem de Mello Bianchi-Ferraro, Fábio Fernando de Araújo, Marair Grácio Ferreira Sartori, Manoel Joâo Batista Castello Girão · 2016 · Revista da Associação Médica Brasileira
  7. Contraception in Patients with Rheumatic Disease
    Lisa R. Sammaritano · 2017 · Rheumatic Disease Clinics of North America
  8. Physician Attitudes Toward Over the Counter Availability for Oral Contraceptives
    David Leighton Howard, Jeffrey W Wall, Julie Lubker Strickland · 2012 · Maternal and Child Health Journal
  9. Pregnancy and pulmonary artery hypertension: Management challenges
    Gurleen Wander, Claudia Montanaro, Prithvi Dixit, Daryl P. Dob, Mark Richard Johnson, Roshni Patel · 2025 · International Journal of Cardiology Congenital Heart Disease
  10. Update on specificities of stroke in women
    Hanne Christensen, Line Bentsen, Louisa Marguerite Christensen · 2016 · La Presse Médicale
  11. New insights into treatment of venous thromboembolism
    Stephan Moll · 2014 · Hematology
  12. The use of progestogen-only pill in migraine patients
    Gianni Allais, Giulia Chiarle, Fabiola Bergandi, Chiara Benedetto · 2015 · Expert Review of Neurotherapeutics
  13. Effect of the injectable contraceptive depot‐medroxyprogesterone acetate on coagulation parameters in new users
    Vaneska Melhado‐Kimura, Joyce Maria Annichino‐Bizzacchi, Susan Kelly Picoli Quaino, Silmara Lima Montalvão, Luis Guillermo Bahamondes, Arlete Maria dos Santos Fernandes · 2017 · Journal of obstetrics and gynaecology research
  14. Contraceptive methods and issues around the menopause: an evidence update
    Shagaf H. Bakour, Archana Hatti, Susan Whalen · 2017 · The Obstetrician & Gynaecologist
  15. Safety of current strategies to manage moderate to severe pain in patients with endometriosis
    Simone Ferrero, Fabio Barra, Giulia Vatteroni, Francesco Paolo Rosato, Giulio Evangelisti, Michele Paudice, Valerio Gaetano Vellone · 2025 · Expert Opinion on Drug Safety
  16. Sex Hormone Profiles in Patients With Torsades de Pointes Ventricular Tachycardia
    Pietro Enea Lazzerini, Vamsi Krishna Murthy Ginjupalli, Jean‐Baptiste Reisqs, Iacopo Bertolozzi, Silvia Cantara, Maria Grazia Castagna, Riccardo Accioli, Antonio D’Errico, Alessandra Cartocci, Anna Cantore et al. · 2025 · JACC. Clinical electrophysiology
  17. Prothrombotic biomarkers during controlled ovarian stimulation for assisted reproductive technology
    Justine Hugon‐Rodin, Alessandro Casini, Julie Bénard, Antoine Poncet, Véronique Raverot, Pierre Fontana, Nicolas R. Vulliémoz, Isabelle Streuli · 2023 · Fertility and Sterility
  18. Contraceptive Care in the Rheumatic Diseases
    Nicole M. Luche, Mehret Birru Talabi · 2024 · JCR Journal of Clinical Rheumatology
  19. Pregnancy in Women Receiving Maintenance Dialysis
    Cristina Adriana Popa, Priyadarshini John, Prasoon Verma, Sehrish Ali, Silvi Shah · 2024 · Kidney Medicine
  20. Drospirenone detected in postmortem blood of a young woman with pulmonary thromboembolism: A case report and review of the literature
    Nozomi Idota, Masaki Kobayashi, Daisuke Miyamori, Yasuhiro Kakiuchi, Hiroshi Ikegaya · 2014 · Legal Medicine
  21. Discontinuation of hormonal contraception in Oman: prevalence and reasons
    Fatma Al-Ghashri, Habiba Al-Harthi, Maryam Al Shukri, Asma Said Al Shidhani · 2021 · Eastern Mediterranean Health Journal
  22. Pregnancy and Autoimmune Disease, Reproductive and Hormonal Issues
    Eliza F. Chakravarty, Lisa R. Sammaritano · 2019 · Elsevier eBooks
  23. A multicenter, randomized, placebo-controlled, double-blind, comparative study of dienogest at 1 mg/day in patients with primary and secondary dysmenorrhea
    Yutaka Osuga, Kôichi Hayashi, Shingo Kanda · 2020 · Fertility and Sterility
  24. Hormonal Contraception
    Rebecca H. Allen, Andrew M. Kaunitz, Martha Hickey · 2016 · Elsevier eBooks
  25. Contraception and Sterilization
    Sharon Tracey Cameron · 2018 · Wiley eBooks
  26. Contraceptive considerations for women with gastrointestinal disorders
    Sridhar, Aparna, Cwiak, Carrie A., Kaunitz, Andrew M., Allen, Rebecca H. · 2017 · Digestive Diseases and Sciences
  27. Alignment of contraception use with the ACR reproductive health guidelines in women with systemic lupus erythematosus within the RISE registry
    Megan E. B. Clowse, Jing Li, Amanda G. Snyderman, Gabriela Schmajuk · 2024 · Lupus Science & Medicine
  28. Society of Family Planning Committee Statement: Contraception and body weight
    Noor Zwayne, Elizabeth Lyman, Ashley Morgan Ebersole, Jessica Elizabeth Morse · 2024 · Contraception
  29. Profil des effets indésirables de l’implant d’étonogestrel (Nexplanon®, Implanon®) déclarés en France
    Corinne Simon, M.‐S. Agier, Johana Béné, Clotilde Muller, Laura Vrignaud, Henri Marret, A.‐P. Jonville‐Béra · 2016 · Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément/Journal de gynécologie obstétrique et biologie de la reproduction
  30. Contraception and Venous Thromboembolism: Risk Factors and Clinical Considerations
    Ashley Waddington, Carrie Ferguson, Robert L. Reid · 2016 · Open Journal of Obstetrics and Gynecology
  31. Contracepção para adolescentes com doenças reumáticas crônicas
    Benito Lourenço, Kátia Tomie Kozu, Gabriela Nunes Leal, Marco F. Silva, Elisabeth Gonzaga Canova Fernandes, Camila M.P. França, Fernando Henrique Carlos de Souza, Clóvis A. Silva · 2016 · Revista Brasileira de Reumatologia
  32. Thrombophilia
    Jason A. Freed, Kenneth Alan Bauer · 2019 · Elsevier eBooks
  33. Contraception and Sterilization
    Sharon Tracey Cameron, Anna F. Glasier · 2012 · Wiley-Blackwell eBooks
  34. Progestin isoforms provide different levels of protein S expression in HepG2 cells
    Toshihiro Kozuka, Shogo Tamura, Nami Kawamura, Yukiko Nakata, Ryo Hasebe, Ayumi Makiyama, Yuki Takagi, Moe Murata, Naoki Mizutani, Akira Takagi et al. · 2016 · Thrombosis Research
  35. La contraception après 40 ans. RPC Contraception CNGOF
    M. Lambert, Emmanuelle Begon, Claude Hocké · 2018 · Gynécologie Obstétrique Fertilité & Sénologie
  36. The Antiphospholipid Syndrome
    David P. D’Cruz, Jason S. Knight, Lisa R. Sammaritano, Jane E. Salmon, Ricard Cervera, Munther A. Khamashta · 2023 · Springer eBooks
  37. The Antiphospholipid Syndrome in the Pediatric Population
    Elizabeth E. Sloan, Deborah McCurdy · 2022 · Advances in Pediatrics
  38. Venous thromboembolism associated with medically assisted reproduction (MAR): British fertility society policy and practice guidance for assessment and prevention
    Neerujah Balachandren, Srividya Seshadri, Ephia Yasmin, Wael Saab, Carolyn Gates, Zara Sayar, Hannah Cohen, Lisa J. Webber · 2024 · Human Fertility
  39. Hormone-related thrombosis: duration of anticoagulation, risk of recurrence, and the role of hypercoagulability testing
    Luuk J.J. Scheres, Saskia Middeldorp · 2024 · Hematology
  40. The 2024 US Medical Eligibility Criteria for Contraceptive Use: Application to Practice in the Care of Patients With Cardiac Disease
    Kayle S. Shapero, Tessa E. Madden · 2025 · Circulation Research
  41. Contraception orale et risque vasculaire
    Philippe Bouchard, Alfred Spira, Yves G. Ville, J. Conard, Regine L. Sitruk-Ware · 2013 · Bulletin de l Académie Nationale de Médecine
  42. Preconception counseling of females with inflammatory bowel disease
    Amihai Rottenstreich, Ariella Bar‐Gil Shitrit · 2020 · Best Practice & Research Clinical Gastroenterology
  43. A Comprehensive Literature Review on Managing Systemic Lupus Erythematosus: Addressing Cardiovascular Disease Risk in Females and Its Autoimmune Disease Associations
    Saleha Dar, Sabina Koirala, Arooba Khan, Mounika Deepthi Bellary, Arya V Patel, Bejoi Mathew, Rahul Singh, Nahida Baigam, Waleed Razzaq, Zain Ul Abdin et al. · 2023 · Cureus
  44. Homonymous hemianopsia as the presenting sign of migrainous infarction
    Giovanni Campagna, Aroucha Vickers, Claudia M. Prospero Ponce, Andrew G. Lee · 2018 · Canadian Journal of Ophthalmology
  45. Contraceptive Devices for Women: Implants, Intrauterine Devices and Other Products
    Julie Craik, Sam Rowlands · 2014 · Springer eBooks
  46. Society of Family Planning Committee Statement: Contraceptive considerations for individuals with cancer and cancer survivors part 1 – Key considerations for clinical care Joint with the Society of Gynecologic Oncology
    Pelin Batur, Ashley R. Brant, Carolyn Kay McCourt, Eleanor Bimla Schwarz · 2025 · Contraception
  47. Efficacy of Uterine Artery Embolization for Treatment of Anticoagulant-Associated Abnormal Uterine Bleeding
    Kapil Wattamwar, Moona Arabkhazaeli, JaHyun Shin, Ricki A. Korff, Jacob Cynamon, Yosef S. Golowa · 2021 · Journal of Minimally Invasive Gynecology
  48. Risk of venous thromboembolism in people with RA: a population-based study in the UK
    Mark Russell, Katie Bechman, Mark Gibson, Victoria Basey, Michael Mclean, Saqib Rana, Anna Barkaway, Simon de Lusignan, Maya H Buch, James Benjamin Galloway · 2025 · Rheumatology
  49. Economic evaluation of a novel genetic screening test for risk of venous thromboembolism compared with standard of care in women considering combined hormonal contraception in Switzerland
    C. Simone Sutherland, Zanfina Ademi, Jöelle Michaud, Nadine Schur, Myriam Lingg, Arjun Bhadhuri, Thierry D. Pache, Johannes Bitzer, Pierre Suchon, Valerie Albert et al. · 2019 · BMJ Open
  50. Russian Eligibility Criteria for Prescribing Menopausal Hormone Therapy to Patients With Cardiovascular and Metabolic Diseases. Consensus Document of RSC, RSOG, RAE, EUAT, RAP
    Evgeny V. Shlyakhto, Gennady Tikhonovich Sukhikh, Vladimir Nikolaevich Serov, Ivan Ivanovich Dedov, G. P. Arutyunov, Igor Aleksandrovich Suchkov, Yа. A. Orlova, Elena Nikolaevna Andreeva, Svetlana V Yureneva, I. S. Yavelov et al. · 2023 · Kardiologiia
  51. Combined Hormonal Contraceptives and First Venous Thrombosis in Young French Women: Impact of Thrombotic Family History
    Justine Hugon‐Rodin, Marie‐Hélène Horellou, J. Conard, Anne Gompel, Geneviève Plu‐Bureau · 2017 · Journal of the Endocrine Society
  52. Pulmonary Arterial Hypertension and Pregnancy
    Shibba Takkar Chhabra, Gurleen Kaur, Gagandeep Singh Nagi, Rohit Tandon, Abhishek Goyal, Bhupinder Singh, Naved Aslam, Bishav Mohan, Gurpreet Singh Wander · 2018 · Indian Journal of Cardiovascular Disease in Women
  53. Thromboembolism and Oral Contraceptives During the COVID-19 Pandemic: A Disproportionality Analysis Within the Spanish Pharmacovigilance Database
    Luis H. Martín Arias, María Sáinz-Gil, Ester Navarro-García, Inés Salado Valdivieso, Rosario Sanz Fadrique · 2022 · Drugs - Real World Outcomes
  54. Selection of Contraceptive Therapy for Patients with Thrombophilia: A Review of the Evidence
    Whitney D. Maxwell, Merna Jacob, Lisa Beth Spiryda, Charles L. Bennett · 2014 · Journal of Women s Health
  55. Consensus canadien sur la contraception (3e partie de 4) : chapitre 8 – contraception à progestatif seul
    Amanda Black, Édith Guilbert, Dustin Costescu, Sheila Dunn, William A. Fisher, Sari Leanne Kives, Melissa Mirosh, Wendy V. Norman, Helen C. Pymar, Robert L. Reid et al. · 2016 · Journal of Obstetrics and Gynaecology Canada
  56. Russian eligibility criteria for prescription of menopausal hormone therapy to patients with cardiovascular and metabolic diseases. Agreement document of RKO, ROAG, RAE, EAT, AFR, RNMOT, RAGG
    E. V. Shlyakhto, Ivan Ivanovich Dedov, Vladimir Nikolaevich Serov, G. T. Sukhikh, G. P. Arutyunov, I. A. Suchkov, Oksana M. Drapkina, O N Tkacheva, Ya. A. Orlova, I.A. Baranov et al. · 2026 · Problems of Endocrinology
  57. Long-Acting Reversible Contraception in the Pediatric Emergency Department
    Atsuko Koyama, David H. Dorfman, Michelle M. Forcier · 2015 · Pediatric Emergency Care
  58. Depo-Provera (depot medroxyprogesterone acetate) use after bariatric surgery
    A. Murthy, Clarissa J. Lam · 2016 · Open Access Journal of Contraception
  59. Long-term contraceptive care in obese and superobese women
    Johannes Bitzer · 2020 · Elsevier eBooks
  60. Navigating risk: Effect of counseling on contraception practice in urban Hispanic women with systemic lupus erythematosus
    Oleg Stens, Katherine Ruddy, Jack Rodman, Leanna Marderian Wise · 2025 · International Journal of Gynecology & Obstetrics
  61. Efficacy and Safety of 48-Week Low-Dose Dienogest Treatment in Patients with Endometriosis-Associated Dysmenorrhea: A Randomized, Open-Label, Parallel-Group Trial
    Kyoko Kikuno, Ryuta Asada, Takuma Ishihara, Ken-ichirou Morishige, Kenro Chikazawa, Tatsuro Furui, Masanori Isobe · 2025 · Advances in Therapy
  62. Challenges in Family Planning and Pregnancy for Women with Rheumatic Diseases
    Caroline H. Siegel, Lisa R. Sammaritano · 2023 · touchREVIEWS in RMD
  63. Pregnancy after transplant in the older adolescent: Anticipatory guidance for the pediatric provider
    Lisa A. Coscia, Dorothy Kliniewski, S Constantinescu, Michael J. Moritz · 2024 · Pediatric Transplantation
  64. Contraception in Neurologic and Psychiatric Disorders
    Caryn Dutton, Andrea Hsu Roe, Deborah Bartz · 2019 · Springer eBooks
  65. The best method of contraception for smokers (a review)
    Tatyana Yu. Pestrikova, Elena A. Yurasova, Igor V. Yurasov · 2016 · Russian Journal of Human Reproduction
  66. Planificación familiar: esterilidad
    A. Ramírez Hidalgo, A. Avecilla Palau · 2014 · Dialnet (Universidad de la Rioja)
  67. The Oral Contraceptive Pill and Adolescents' Mental Health
    Ana Costa-Ramón, N. Meltem Daysal, Ana Rodríguez‐González · 2023 · SSRN Electronic Journal
  68. Risk of venous thromboembolism associated with chlormadinone acetate- and levonorgestrel-containing combined oral contraceptives – Insights from the retrospective RIVET-RCS study
    Pauline De Corte, Moritz Klinghardt, Anja Bauerfeind, Tanja Boehnke, Klaas Heinemann · 2025 · Contraception
  69. Central Retinal Vein Occlusion Associated With Progestin‐Only Contraceptive Implant Use
    J. Chu, David Ik Tuo Sia · 2025 · Case Reports in Ophthalmological Medicine
  70. Russian Eligibility Criteria for Prescribing Menopausal Hormone Therapy to Patients With Cardiovascular and Metabolic Diseases. Consensus Document of RSC, RSOG, RAE, EUAT, RAP, RSMSI, RAGG
    E.V. Shlyakhto, Ivan Ivanovich Dedov, Vladimir Nikolaevich Serov, G. T. Sukhikh, G. P. Arutyunov, I. A. Suchkov, Oksana M. Drapkina, Olga N. Tkacheva, Yа. A. Orlova, I.A. Baranov et al. · 2025 · Kardiologiia
  71. Pro und Contra der Thrombophiliediagnostik/Pros and cons of thrombophilia testing
    Matthias Orth, Kathrin Schlatterer · 2013 · Journal of Laboratory Medicine
  72. Hormone Therapy in the Transition Period of a Woman’s Life
    I.V. Kuznetsova · 2020 · Effective Pharmacotherapy
  73. Gravidanza e malattie autoimmuni
    Guest Editors P. Gnerre · 2021 · Italian Journal of Medicine
  74. Pregnancy and reproductive health issues in systemic lupus erythematosus
    Eliza F. Chakravarty, Lisa R. Sammaritano · 2024 · Elsevier eBooks
  75. The impact of hormonal intrauterine device use on health-related quality of life in women with a history of venous thromboembolism: a systematic review
    Júnea Chagas, Juliana Almeida Oliveira, Elaine Cristina Fontes de Oliveira, Gabriella Braga Andrade Martins, Flávia Ribeiro de Oliveira, Daniel Dias Ribeiro, Ana Luiza Lunardi Rocha · 2025 · The European Journal of Contraception & Reproductive Health Care
  76. Porto-spleno-mesenteric thrombosis secondary to medroxyprogesterone acetate as a treatment for abnormal uterine bleeding: a case report
    David J Alvarez Chavez, Javier A Maciel Urzua, Maria C Torres González, Carlos A Bautista López, Carla M Cruz Rocha, Esther A Casado De La Torre, Daniela Itzel Sanchez lozano · 2025 · Journal of Surgical Case Reports
  77. Contraception for Women with Rheumatologic Disease
    Kelly R. Culwell, Geraldine M. Navarro · 2014 · Springer eBooks
  78. Contraceptive Options for Women with Thrombophilia and Thromboembolic Disease
    Jennifer Salcedo, Aparna Sridhar, Tina Rizack · 2014 · Springer eBooks
  79. Presentation and Significance of Venous Thromboembolism
    Meera R. Sridharan, Aneel A. Ashrani · 2017 · Springer eBooks
  80. Anticoagulation for Proximal Deep Vein Thrombosis
    Alfred Ian Lee, Eun‐Ju Lee · 2017 · Springer eBooks
  81. Contraception for Women with Diabetes
    Sushila Arya, Sanja Plavsic Kupesic · 2017 · Springer eBooks
  82. Place of progestogenic oral contraceptives in gynecological practice
    Irina V. Kuznetsova · 2019 · Medical alphabet
  83. Contraception in Systemic Lupus Erythematosus (SLE)
    Faizan Shaukat, Stephanie Keeling · 2019 · Current Treatment Options in Rheumatology
  84. Contraception
    AnnaF. Glasier · 2015 · Elsevier eBooks
  85. Obesity and venous thromboembolism
    Julia Czuprynska, Roopen Arya · 2020 · Elsevier eBooks
  86. Contraceptive choices for women before and after bariatric surgery
    Agnieszka Jurga-Karwacka, Johannes Bitzer · 2020 · Elsevier eBooks
  87. “What will happen in the future?” A personal VTE journey
    Ellen O’Rourke, Shane Toolan, Anne Bedos, Alexandra Tierney, Cormac J. Jennings, Annemarie O’Neill, Fionnuala Ní Áinle, Barry Kevane · 2020 · Thrombosis Update
  88. Pulmonary hypertension in pregnancy
    K. Durga, S Yuvarajan, R Vetrivel Praveen, Antonious Maria Selvam, Yashoda, V. Karthiga · 2021 · International Journal of Reproduction Contraception Obstetrics and Gynecology
  89. Perspective Chapter: Modern Birth Control Methods
    Rahma Al Kindi, Asma Ali Al Salmani, Rahma Al Hadhrami, Sanaa Al Sumri, Hana Harib Al Sumri · 2022 · IntechOpen eBooks
  90. Contraception in adolescents with obesity and diabetes mellitus
    Maria Rustemovna Shaydullina, Farida Vadutovna Valeeva, A. F. Soubchankoulova, P. A. Khusieva · 2022 · Problems of Endocrinology
  91. Reproductive Health in the Rheumatic Diseases
    Julia Sun, Laura Andréoli, Jane E. Salmon, Meghan Clowse, Caroline Gordon, Jill P. Buyon, Rosalind Ramsey‐Goldman, Lisa R. Sammaritano · 2023 · Springer eBooks
  92. Contraception for Women with Hematologic Abnormalities
    Kristina M. Tocce, S. Lindsey Davis · 2014 · Springer eBooks
  93. Contraceptive options for women with SLE: response to Mansour letter
    Kelly R. Culwell, Kathryn M. Curtis · 2013 · Journal of Family Planning and Reproductive Health Care
  94. Venous thromboembolism in women : an assessment of hormonal, genetic and other risk factors
    Annica Bergendal · 2013 · Figshare
  95. La maladie veineuse thromboembolique chez la femme jeune :etude descriptive des facteurs de risque sur 300 patientes
    Carole Azoulai · 2014 · HAL
  96. Hormontherapie bei Thrombophilie
    Bettina Tóth, Andreas Rank, C. Franz, Michael Z. Ludwig · 2013 · Der Gynäkologe
  97. The Progestin-Only-Pill (POP) is not a Niche Option: New Preclinical and Clinical Data about the Interrelations between Levonorgestrel-Dosage, Peripheral as well as Central Contraceptive Effects and Bleeding Behavior
    Michael Oettel, Kochhar Ps, Hermann Osterwald, Zarapkar Ms, Rajalaxmi Walavalkar · 2016 · Journal für Kardiologie (Krause & Pachernegg GmbH)
  98. Individualizing Selection of Hormonal Contraception
    Erin C. Raney, Shannon C. Scott, Kimberly A. B. Cauthon · 2014 · Osteopathic Family Physician
  99. Efeito do sistema intrauterino liberador de levonorgestrel sobre marcadores de risco metabólico e doença cardiovascular em mulheres obesas: ensaio clínico randomizado
    Lucimara Facio Nobre Zueff · 2016
  100. Pros and cons of thrombophilia testing1)
    Matthias Orth, Kathrin Schlatterer · 2013 · Journal of Laboratory Medicine